- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07704008
The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.
The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).
Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.
Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Ankara, Turquie (Türkiye), 06200
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Receiving hemodialysis treatment for the first time.
- Age ≥18 years.
- No visual, hearing, or cognitive impairment.
- Able to communicate effectively.
- Clinically stable.
- No diagnosed psychiatric disorder or use of psychiatric medication.
- No history of seizures.
- Willing and able to provide informed consent.
Exclusion Criteria:
- Previous hemodialysis treatment.
- Age <18 years.
- Visual, hearing, or cognitive impairment.
- History of kidney transplantation.
- Communication difficulties.
- Diagnosed psychiatric disorder or use of psychiatric medication.
- History of seizures.
- Declined to participate in the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
|
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes.
The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
|
Comparateur actif: Control Group
Participants received standard hemodialysis care without any additional intervention.
|
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Systolic Blood Pressure
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in systolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Diastolic Blood Pressure
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in diastolic blood pressure measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Heart Rate
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in heart rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Respiratory Rate
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in respiratory rate measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Change in Body Temperature
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in body temperature measured before and after the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
State Anxiety Level After Hemodialysis
Délai: Immediately after completion of the hemodialysis session.
|
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Pain Score
Délai: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate greater pain.
Pain was assessed before and immediately after completion of the hemodialysis session.
|
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
|
|
Participant Satisfaction Score
Délai: Immediately after completion of the hemodialysis session.
|
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied.
Higher scores indicate greater participant satisfaction.
Assessment was performed immediately after completion of the hemodialysis session.
|
Immediately after completion of the hemodialysis session.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- AYBU-2023-208
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .